References
- Limouzin-Lamothe MA, Mairon N, Joyce CR, Le Gal M. Quality of life after the menopause: influence of hormonal replacement therapy. Am J Obstet Gynecol. 1994; 170:618-24.10.1016/S0002-9378(94)70239-X7509570
- Report of the International Conference on Population and Development UNFPA. 1995.
- Soules MR, Bremner WJ. The menopause and climacteric: endocrinologic basis and associated symptomatology. J Am Geriatr Soc. 1982; 30:547-61.10.1111/j.1532-5415.1982.tb05661.x7050219
- Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002; 288:321-33.10.1001/jama.288.3.32112117397
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008; 107: 103-11.17333341
- The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause. 2012; 19:257-71.22367731
- Sturdee DW, Pines A, International Menopause Society Writing Group, Archer DF, Baber RJ, Barlow D, et al. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric. 2011; 14: 302-20.10.3109/13697137.2011.57059021563996
- Heinemann LA, Potthoff P, Schneider HP. International versions of the Menopause Rating Scale (MRS). Health Qual Life Outcomes. 2003; 1:28.10.1186/1477-7525-1-2812914663
- Hilditch JR, Lewis J, Peter A, van Maris B, Ross A, Franssen E, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas. 1996; 24:161-75.10.1016/0378-5122(96)01038-98844630
- EuroQol Group Executive Office. How to obtain EQ-5D 2013; Available from: http://www.euroqol.org/eq-5d-products/how-to-obtain-eq-5d.html.
- SF-36 Health Survey Update [database on the Internet]. Available from: www.SF36.org.
- North American Menopause Society. [13 Dec, 2004]; Available from: www.menopause.org.
- Fallahzadeh H. Quality of life after the menopause in Iran: a population study. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation. 2010; 19:813-9.10.1007/s11136-010-9644-220358299
- Żołnierczuk-Kieliszek D, Kulik TB, Jarosz MJ, Stefanowicz A, Pacian A, Pacian J, Janiszewska M. Quality of life in peri- and post-menopausal Polish women living in Lublin Province – differences between urban and rural dwellers. Ann Agric Environ Med. 2012; 19:129-33.
- Norozi E, Mostafavi F, Hasanzadeh A, Moodi M, Sharifirad G. Factors affecting quality of life in postmenopausal women, Isfahan, 2011. J Educ Health Promot. 2013; 2:58. 10.4103/2277-9531.12085724520556
- Maartens LW, Knottnerus JA, Pop VJ. Menopausal transition and increased depressive symptomatology: a community based prospective study. Maturitas. 2002; 42:195-200.1216104310.1016/S0378-5122(02)00038-5
- Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry. 2004; 61:62-70.1470694510.1001/archpsyc.61.1.62
- Whiteley J, DiBonaventura M, Wagner JS, Alvir J, Shah S. The impact of menopausal symptoms on quality of life, productivity, and economic outcomes. J Womens Health (Larchmt). 2013; 22:983-90.2408367410.1089/jwh.2012.3719
- Maartens LW, Leusink GL, Knottnerus JA, Smeets CG, Pop VJ. Climacteric complaints in the community. Fam Pract. 2001; 18:189-94.10.1093/fampra/18.2.18911264270
- Porter M, Penney GC, Russell D, Russell E, Templeton A. A population based survey of women’s experience of the menopause. Br J Obstet Gynaecol. 1996; 103: 1025-8.10.1111/j.1471-0528.1996.tb09555.x8863703
- Gracia CR, Sammel MD, Freeman EW, Liu L, Hollander L, Nelson DB. Predictors of decreased libido in women during the late reproductive years. Menopause. 2004; 11:144-50.1502144310.1097/01.GME.0000082147.01218.CF
- Pines A, Sturdee DW, MacLennan AH. Quality of life and the role of menopausal hormone therapy. Climacteric. 2012; 15:213-6.2261260610.3109/13697137.2012.655923
- MacLennan A, Lester S, Moore V. Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric. 2001; 4:58-74.10.1080/cmt.4.1.58.7411379379
- Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA. 2002; 287:591-7.10.1001/jama.287.5.59111829697
- Welton AJ, Vickers MR, Kim J, Ford D, Lawton BA, MacLennan AH, et al. Health related quality of life after combined hormone replacement therapy: randomised controlled trial. BMJ. 2008; 337:a1190. doi:10.1136/bmj.a1190.18719013
- Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med. 2003; 348:1839-54.10.1056/NEJMoa03031112642637
- Greendale GA, Reboussin BA, Hogan P, Barnabei VM, Shumaker S, Johnson S, et al. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol.1998; 92:982-8.9840563